Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 3

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 3
---
ENDIX B                                                                                                                                                                                                                                  | 42 |

i

QUESTIONS AND ANSWERS

| Q: | When is the Annual Meeting? |

| Q: | Where will the Annual Meeting be held? |

| A. | The Annual Meeting will be held virtually by means of a live webcast, as further described herein, which can be accessed at www.virtualshareholdermeeting.com/MBIO2025 when you enter your 16-digit control number included with your proxy card. |

| Q: | What is the purpose of the Annual Meeting? |

| A. | At the Annual Meeting, our stockholders will act upon the matters outlined in the Notice of Annual Meeting of Stockholders accompanying this proxy statement, including (i) the election of seven directors for a term of one year, (ii) the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025, (iii) the approval of an amendment to the Company’s 2019 Employee Stock Purchase Plan to increase the number of shares issuable by 250,000 shares and increase the number of shares subject to a Purchase Right thereunder to 10,000, (iv) the approval of an amendment to the Company’s 2016 Incentive Plan to increase the number of shares issuable by 2,500,000 shares and (v) the transaction of any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof. |

| Q. | Who is entitled to vote at our Annual Meeting? |

| A. | Only stockholders of record at the close of business on, November 18, 2025, which we refer to as the Record Date, are entitled to receive notice of the Annual Meeting and to vote the shares that they held on that date at the Annual Meeting, or any adjournment or postponement thereof.  As of the close of business on the Record Date, we had 6,453,701 shares of common stock outstanding, 845,385 shares of Class A common stock outstanding (which converts to 1,127 shares of common stock), and 250,000 shares of Class A Preferred Stock outstanding (which converts to 333 shares of common stock).  Each share of common stock entitles its holder to one vote at the Annual Meeting, each share of Class A common stock entitles its holder to one-seven hundred fiftieth of one vote, and each share of Class A